Ohcanbohtosat - Peter Manley

  • Čájehuvvo 1 - 19 / 19
Aiddostahte ozu
  1. 1
    Medical and Psychosocial Correlates of Insomnia Symptoms in Adult Survivors of Pediatric Brain Tumors

    Medical and Psychosocial Correlates of Insomnia Symptoms in Adult Survivors of Pediatric Brain Tumors Dahkki Eric S. Zhou, Peter Manley, Karen J. Marcus, Christopher J. Recklitis

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors

    Incidence, risk factors, and longitudinal outcome of seizures in long-term survivors of pediatric brain tumors Dahkki Nicole J. Ullrich, Scott L. Pomeroy, Kush Kapur, Peter Manley, Liliana Goumnerova, Tobias Loddenkemper

    Almmustuhtton 2015
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Parent-reported cognition of children with cancer and its potential clinical usefulness

    Parent-reported cognition of children with cancer and its potential clinical usefulness Dahkki Jin‐Shei Lai, Frank Zelko, Kevin R. Krull, David Cella, Cindy J. Nowinski, Peter Manley, Stewart Goldman

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Cancer Treatment-Related Infertility: A Critical Review of the Evidence

    Cancer Treatment-Related Infertility: A Critical Review of the Evidence Dahkki Philip D. Poorvu, A. Lindsay Frazier, Angela M. Feraco, Peter Manley, Elizabeth S. Ginsburg, Marc R. Laufer, Ann S. LaCasce, Lisa Diller, Ann H. Partridge

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas

    Phase II trial of pegylated interferon alfa-2b in young patients with neurofibromatosis type 1 and unresectable plexiform neurofibromas Dahkki Regina I. Jakacki, Eva Dombi, Seth M. Steinberg, Stewart Goldman, Mark W. Kieran, Nicole J. Ullrich, Ian F. Pollack, Anne Goodwin, Peter Manley, Jason Fangusaro, Rudy Allen, Brigitte C. Widemann

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma

    Multiplexed immunofluorescence reveals potential PD-1/PD-L1 pathway vulnerabilities in craniopharyngioma Dahkki Shannon Coy, Rumana Rashid, Jia‐Ren Lin, Ziming Du, Andrew M. Donson, Todd C. Hankinson, Nicholas K. Foreman, Peter Manley, Mark W. Kieran, David A. Reardon, Peter K. Sorger, Sandro Santagata

    Almmustuhtton 2018
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database

    Long‐term outcome of 4,040 children diagnosed with pediatric low‐grade gliomas: An analysis of the Surveillance Epidemiology and End Results (SEER) database Dahkki Pratiti Bandopadhayay, Guillaume Bergthold, Wendy B. London, Liliana Goumnerova, Andrés Morales La Madrid, Karen J. Marcus, Dongjing Guo, Nicole J. Ullrich, Nathan Robison, Susan Chi, Rameen Beroukhim, Mark W. Kieran, Peter Manley

    Almmustuhtton 2014
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival

    Rethinking childhood ependymoma: a retrospective, multi-center analysis reveals poor long-term overall survival Dahkki Amanda Marinoff, Clement Ma, Dongjing Guo, Matija Snuderl, Karen Wright, Peter Manley, Hasan Al‐Sayegh, Claire Sinai, Nicole J. Ullrich, Karen J. Marcus, Daphne A. Haas‐Kogan, Liliana Goumnerova, Wendy B. London, Mark W. Kieran, Susan Chi, Jason Fangusaro, Pratiti Bandopadhayay

    Almmustuhtton 2017
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Clinical and treatment factors determining long‐term outcomes for adult survivors of childhood low‐grade glioma: A population‐based study

    Clinical and treatment factors determining long‐term outcomes for adult survivors of childhood low‐grade glioma: A population‐based study Dahkki Rahul Krishnatry, Nataliya Zhukova, Ana Guerreiro Stücklin, Jason D. Pole, Matthew Mistry, Iris Fried, Vijay Ramaswamy, Ute Bartels, Annie Huang, Normand Laperrière, Peter B. Dirks, Paul C. Nathan, Mark Greenberg, David Malkin, Cynthia Hawkins, Pratiti Bandopadhayay, Mark W. Kieran, Peter Manley, Éric Bouffet, Uri Tabori

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma

    Phase I study of gene-mediated cytotoxic immunotherapy with AdV-tk as adjuvant to surgery and radiation for pediatric malignant glioma and recurrent ependymoma Dahkki Mark W. Kieran, Liliana Goumnerova, Peter Manley, Susan Chi, Karen J. Marcus, Andrea G. Manzanera, Maria Lucia Silva Polanco, Brian W. Guzik, Estuardo Aguilar-Córdova, C. Marcela Díaz‐Montero, Arthur J. DiPatri, Tadanori Tomita, Rishi Lulla, Lianne Greenspan, Laura K. Aguilar, Stewart Goldman

    Almmustuhtton 2019
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer

    A phase II trial of a multi‐agent oral antiangiogenic (metronomic) regimen in children with recurrent or progressive cancer Dahkki Nathan Robison, Federico Campigotto, Susan Chi, Peter Manley, Christopher D. Turner, Mary Ann Zimmerman, Christine Chordas, Annette M. Werger, Jeffrey C. Allen, Stewart Goldman, Joshua B. Rubin, Michael S. Isakoff, Wilbur J. Pan, Ziad Khatib, Melanie Comito, Anne Bendel, Jay B. Pietrantonio, Laura Kondrat, Shannon Hubbs, Donna Neuberg, Mark W. Kieran

    Almmustuhtton 2013
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibromatosis Clinical Trials Consortium study

    A phase II study of continuous oral mTOR inhibitor everolimus for recurrent, radiographic-progressive neurofibromatosis type 1–associated pediatric low-grade glioma: a Neurofibroma... Dahkki Nicole J. Ullrich, Sanjay P. Prabhu, Alyssa Reddy, Michael J. Fisher, Roger J. Packer, Stewart Goldman, Nathan Robison, David H. Gutmann, David Viskochil, Jeffrey C. Allen, Bruce R. Korf, Alan Cantor, Gary Cutter, Coretta Thomas, John P. Perentesis, Tomoyuki Mizuno, Alexander A. Vinks, Peter Manley, Susan Chi, Mark W. Kieran

    Almmustuhtton 2020
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor

    Intensive Multimodality Treatment for Children With Newly Diagnosed CNS Atypical Teratoid Rhabdoid Tumor Dahkki Susan Chi, Mary Ann Zimmerman, Xiaopan Yao, Kenneth J. Cohen, Peter C. Burger, Jaclyn A. Biegel, Lucy B. Rorke‐Adams, Michael J. Fisher, Anna J. Janss, Claire Mazewski, Stewart Goldman, Peter Manley, Daniel C. Bowers, Anne Bendel, Joshua T. Rubin, Christopher Turner, Karen J. Marcus, Liliana Goumnerova, Nicole J. Ullrich, Mark W. Kieran

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results

    Camonsertib in DNA damage response-deficient advanced solid tumors: phase 1 trial results Dahkki Timothy A. Yap, Elisa Fontana, Elizabeth K. Lee, David R. Spigel, Martin Højgaard, Stéphanie Lheureux, Niharika B. Mettu, Benedito A. Carneiro, Louise Carter, Ruth Plummer, Gregory M. Coté, Funda Meric‐Bernstam, Joseph O’Connell, Joseph D. Schonhoft, Marisa J. Wainszelbaum, Adrian J. Fretland, Peter Manley, Yi Xu, Danielle Ulanet, Victoria Rimkunas, Mike Zinda, María Koehler, Ian M. Silverman, Jorge S. Reis‐Filho, Ezra Rosen

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

    LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RA... Dahkki Cornelis M. van Tilburg, Lindsay Kilburn, Sébastien Perreault, René Schmidt, Amedeo A. Azizi, Ofelia Cruz, Michal Zápotocký, Katrin Scheinemann, Antoinette Y. N. Schouten–van Meeteren, Astrid Sehested, Enrico Opocher, Pablo Hernáiz Driever, Shivaram Avula, David S. Ziegler, David Capper, Arend Koch, Felix Sahm, Jiaheng Qiu, Li‐Pen Tsao, Samuel C. Blackman, Peter Manley, Till Milde, Ruth Witt, David Jones, Darren Hargrave, Olaf Witt

    Almmustuhtton 2024
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas

    Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas Dahkki Priscilla K. Brastianos, Amaro Taylor‐Weiner, Peter Manley, Robert T. Jones, Dora Dias‐Santagata, Aaron R. Thorner, Michael S. Lawrence, Fausto J. Rodríguez, Lindsay A. Bernardo, Laura Schubert, Ashwini Sunkavalli, Nick Shillingford, Monica L. Calicchio, Hart G.W. Lidov, Hala Taha, Maria Martinez‐Lage, Mariarita Santi, Phillip B. Storm, John Y. K. Lee, James N. Palmer, Nithin D. Adappa, R. Michael Scott, Ian F. Dunn, Edward R. Laws, Chip Stewart, Keith L. Ligon, Mai P. Hoang, Paul Van Hummelen, William C. Hahn, David N. Louis, Adam Resnick, Mark W. Kieran, Gad Getz, Sandro Santagata

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors

    Clinical targeted exome-based sequencing in combination with genome-wide copy number profiling: precision medicine analysis of 203 pediatric brain tumors Dahkki Shakti Ramkissoon, Pratiti Bandopadhayay, Jaeho Hwang, Lori Ramkissoon, Noah F. Greenwald, Steven E. Schumacher, Ryan O’Rourke, Nathan Pinches, Patricia Ho, Hayley Malkin, Claire Sinai, Mariella G. Filbin, Ashley Plant, Wenya Linda Bi, Michael S. Chang, Edward Yang, Karen Wright, Peter Manley, Matthew D. Ducar, Sanda Alexandrescu, Hart G.W. Lidov, Ivana Delalle, Liliana Goumnerova, Alanna J. Church, Katherine A. Janeway, Marian H. Harris, Laura E. MacConaill, Rebecca D. Folkerth, Neal I. Lindeman, Charles D. Stiles, Mark W. Kieran, Azra H. Ligon, Sandro Santagata, Adrian M. Dubuc, Susan Chi, Rameen Beroukhim, Keith L. Ligon

    Almmustuhtton 2016
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial

    The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial Dahkki Lindsay Kilburn, Dong-Anh Khuong-Quang, Jordan R. Hansford, Daniel Landi, Jasper van der Lugt, Sarah Leary, Pablo Hernáiz Driever, Simon Bailey, Sébastien Perreault, Geoffrey McCowage, Angela J. Waanders, David S. Ziegler, Olaf Witt, Patricia Baxter, Hyoung Jin Kang, Tim Hassall, Jung Woo Han, Darren Hargrave, Andrea Franson, Michal Oren, Helen Toledano, Valérie Larouche, Cassie Kline, Mohamed S Abdelbaki, Nada Jabado, Nicholas G. Gottardo, Nicolas U. Gerber, Nicholas Whipple, Devorah Segal, Susan Chi, Liat Oren, Enrica Tan, Sabine Mueller, Izzy Cornelio, Lisa McLeod, Xin Zhao, Ashley A. Walter, Daniel Da Costa, Peter Manley, Samuel C. Blackman, Roger J. Packer, Karsten Nysom

    Almmustuhtton 2023
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma

    Prospective feasibility and safety assessment of surgical biopsy for patients with newly diagnosed diffuse intrinsic pontine glioma Dahkki Nalin Gupta, Liliana Goumnerova, Peter Manley, Susan Chi, Donna Neuberg, Mäneka Puligandla, Jason Fangusaro, Stewart Goldman, Tadanori Tomita, Tord D. Alden, Arthur J. DiPatri, Joshua B. Rubin, Karen Gauvain, David D. Limbrick, Jeffrey R. Leonard, J. Geyer, Sarah Leary, Samuel R. Browd, Zhihong Wang, Sandeep Sood, Anne Bendel, Mahmoud G. Nagib, Sharon L. Gardner, Matthias A. Karajannis, David H. Harter, Kanyalakshmi Ayyanar, William Gump, Daniel C. Bowers, Bradley E. Weprin, Tobey J. MacDonald, Dolly Aguilera, Barunashish Brahma, Nathan Robison, Erin N. Kiehna, Mark D. Krieger, Eric Sandler, Philipp R. Aldana, Ziad Khatib, John Ragheb, Sanjiv Bhatia, Sabine Mueller, Anu Banerjee, Amy-Lee Bredlau, S. Gururangan, Herbert E. Fuchs, Kenneth J. Cohen, George I. Jallo, Kathleen Dorris, Michael Handler, Melanie Comito, Mark S. Dias, Kellie J. Nazemi, Lissa Baird, Jeff Murray, Neal I. Lindeman, Jason L. Hornick, Hayley Malkin, Claire Sinai, Lianne Greenspan, Karen Wright, Michael D. Prados, Pratiti Bandopadhayay, Keith L. Ligon, Mark W. Kieran

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: